ChinYang Chemical Corporation carries a market capitalization of 36.40B, placing it among publicly traded companies globally. Its enterprise value stands at 58.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 36.40B |
| Enterprise Value | 58.84B |
ChinYang Chemical Corporation currently has 21.20M shares outstanding.
| Shares Outstanding | 21.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
ChinYang Chemical Corporation trades at a trailing price-to-earnings ratio of 21.25. The price-to-sales ratio is 2.44, and the price-to-book ratio stands at 2.57.
| PE Ratio | 21.25 |
| PS Ratio | 2.44 |
| PB Ratio | 2.57 |
| P/TBV Ratio | 1.19 |
| P/FCF Ratio | -143.47 |
| P/OCF Ratio | -141.45 |
| EV / Sales | 3.08 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 52.59 |
ChinYang Chemical Corporation maintains a current ratio of 0.35, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 38.05, indicating elevated leverage, while an interest coverage ratio of -0.32 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.35 |
| Quick Ratio | 0.16 |
| Debt / Equity | 38.05 |
| Debt / EBITDA | -33.47 |
| Interest Coverage | -0.32 |
| Return on Equity (ROE) | 12.89 |
| Return on Assets (ROA) | 3.10 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -2.84 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 14.76 |
Over the trailing twelve months, ChinYang Chemical Corporation has paid -23.94M in income taxes, reflecting an effective tax rate of 98.80.
| Income Tax | -23.94M |
| Effective Tax Rate | 98.80 |
ChinYang Chemical Corporation's stock has declined approximately -13.93484% over the past 52 weeks. The 50-day moving average sits at 1,916.90, while the 200-day moving average is 2,357.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.93484% |
| 50-Day Moving Average | 1,916.90 |
| 200-Day Moving Average | 2,357.08 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, ChinYang Chemical Corporation generated 19.10B in revenue and converted that into 2.20B in net income, yielding earnings per share of 103.54. EBITDA reached -451.06M, while operating income came in at -451.06M.
| Revenue | 19.10B |
| Gross Profit | 1.87B |
| Operating Income | -451.06M |
| Pretax Income | 2.17B |
| Net Income | 2.20B |
| EBITDA | -451.06M |
| EBIT | -451.06M |
| Earnings Per Share (EPS) | 103.54 |
ChinYang Chemical Corporation holds 2.90B in cash and equivalents against 15.10B in total debt, resulting in a net debt position of 12.10B. Total book value stands at 18.11B, with working capital of -12.13B providing operational flexibility.
| Cash & Cash Equivalents | 2.90B |
| Total Debt | 15.10B |
| Net Debt | 12.10B |
| Equity (Book Value) | 18.11B |
| Book Value Per Share | 854.39 |
| Working Capital | -12.13B |
ChinYang Chemical Corporation produced -329.73M in operating cash flow over the past twelve months. After subtracting -4.65M in capital expenditures, free cash flow totaled -334.38M - equivalent to -15.77 per share.
| Operating Cash Flow | -329.73M |
| Capital Expenditures | -4.65M |
| Free Cash Flow | -334.38M |
| FCF Per Share | -15.77 |
ChinYang Chemical Corporation operates with a gross margin of 9.78, reflecting its pricing power and cost economics. The operating margin of -2.36 and net profit margin of 11.49 provide insight into operational efficiency.
| Gross Margin | 9.78 |
| Operating Margin | -2.36 |
| Pretax Margin | 11.37 |
| Profit Margin | 11.49 |
| EBITDA Margin | -2.36 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 42.89 |
| FCF Yield | -0.70 |
ChinYang Chemical Corporation's most recent stock split took place on March 30, 2009 with a 3:4 split ratio.
| Last Split Date | 3/30/2009 |
| Split Ratio | 3:4 |
ChinYang Chemical Corporation posts an Altman Z-Score of 1.50, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.50 |